INmune Bio (INMB) Analyst & Key Data

Analyst Consensus

Buy0 analysts

Buy

Updated Sep 12, 2026

Total Analysts0

Buy

6

Hold

2

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$2.22

Median Target-100.00%

$0.00

Potential downside vs current price

DCF Value-65.53%

$0.77

Potential downside vs current price

Current Stock Price

$2.22

Median Target-100.00%

$0.00

Potential downside vs current price

DCF Value-65.53%

$0.77

Potential downside vs current price

Analyst Consensus

Buy0 analysts

Buy

Updated Sep 12, 2026

Total Analysts0

Buy

6

Hold

2

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score3.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$2.22

Median Target-100.00%

$0.00

Potential downside vs current price

DCF Value-65.53%

$0.77

Potential downside vs current price

Current Stock Price

$2.22

Median Target-100.00%

$0.00

Potential downside vs current price

DCF Value-65.53%

$0.77

Potential downside vs current price

INmune Bio, Inc.